GLI2-HRD1 axis facilitates 5-FU resistance in gastric cancer cells by regulating ubiquitination degradation of UCK2
5-Fluorouracil (5-FU) is a primary chemotherapeutic agent for treating gastric cancer (GC), yet resistance to 5-FU frequently limits its effectiveness and contributes to poor patient outcomes. This study investigated the molecular mechanisms by which uridine-cytidine kinase 2 (UCK2) influences 5-FU...
Saved in:
| Main Authors: | Chaorong Xue, Xuanzi Zhang, Wanling Yu, Hanbin Lin, Junrong Zhang, Jiawen Liu, Zongqi Weng, Manduo Ouyang, Xinjian Lin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Translational Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523325001548 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CT-based radiomics predicts HRD score and HRD status in patients with ovarian cancer
by: Yujiao Wu, et al.
Published: (2025-01-01) -
Real-World Analysis of HRD Assay Variability in High-Grade Serous Ovarian Cancer: Impacts of BRCA1/2 Mutation Subtypes on HRD Assessment
by: Giovanni Luca Scaglione, et al.
Published: (2025-05-01) -
Preliminary evaluation of ShallowHRD performance compared to HRDetect in familial breast cancer tumors
by: Louise Adel Jensen, et al.
Published: (2025-08-01) -
Regulation of GLI2 by LINC02560 and its role in hepatocellular carcinoma
by: Yunmei Huang, et al.
Published: (2025-07-01) -
Causative Genes of Homologous Recombination Deficiency (HRD)-Related Breast Cancer and Specific Strategies at Present
by: Seigo Nakamura, et al.
Published: (2025-02-01)